← Leaderboards
Marc F Hansen
University Of Connecticut Sch Of Med/Dnt
$4,114,656
Attributed
$4,114,656
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $477.6K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,114,656 · 6
By mechanism
R01$3,398,701 · 4
R21$715,955 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- David W Rowe$20,023,977
- Francisco A Sylvester$1,048,154
Others in their field
Top investigators on “Osteosarcoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$59,413,213
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Timothy J. Triche · University Of Southern California$14,547,053
- Dean W Felsher · Stanford University$11,822,756
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Peter J Houghton · University Of Texas Hlth Science Center$8,450,965
Research focus
OsteosarcomaTumor Suppressor GenesClinical ResearchOsteitis DeformansNorthern BlottingsPolymerase Chain ReactionLoss Of HeterozygosityHuman Genetic Material TagGene ExpressionGenetic SusceptibilityHuman SubjectGel ElectrophoresisOsteoblastsLinkage MappingFamily GeneticsChromosome DisordersAllelesGenotypeAffectMicroarray TechnologyGenetic ScreeningGenetic MarkersNeoplasm /Cancer GeneticsFluorescent In Situ Hybridization
Grant awards (16)
Intercellular Communication in Paget's Disease of Bone$178,596
R21 · FY2022 · AR · contact PI
Intercellular Communication in Paget's Disease of Bone$216,480
R21 · FY2021 · AR · contact PI
ROLE OF EDR3 IN NORMAL DEVELOPMENT AND TUMORIGENESIS$305,716
R01 · FY2007 · AR · contact PI
Mode of Action of SQSTM1 Mutations in Paget's Disease Bone$158,079
R21 · FY2007 · AR · contact PI
ROLE OF EDR3 IN NORMAL DEVELOPMENT AND TUMORIGENESIS$314,847
R01 · FY2006 · AR · contact PI
Mode of Action of SQSTM1 Mutations in Paget's Disease Bone$162,800
R21 · FY2006 · AR · contact PI
ROLE OF EDR3 IN NORMAL DEVELOPMENT AND TUMORIGENESIS$349,443
R01 · FY2005 · AR
ROLE OF EDR3 IN NORMAL DEVELOPMENT AND TUMORIGENESIS$349,443
R01 · FY2004 · AR
Locating Novel Paget's Loci by Tumor Allelotyping$287,750
R01 · FY2004 · AR
ROLE OF EDR3 IN NORMAL DEVELOPMENT AND TUMORIGENESIS$348,570
R01 · FY2003 · AR
Locating Novel Paget's Loci by Tumor Allelotyping$287,750
R01 · FY2003 · AR
Locating Novel Paget's Loci by Tumor Allelotyping$287,588
R01 · FY2002 · AR
Locating Novel Paget's Loci by Tumor Allelotyping$281,400
R01 · FY2001 · AR
CLONING NOVEL GENES FOR PAGETS DISEASE AND OSTEOSARCOMA$198,663
R01 · FY2001 · AR
CLONING AND ANALYSIS OF A NOVEL TUMOR SUPPRESSOR GENE$194,528
R01 · FY2000 · CA
CLONING NOVEL GENES FOR PAGETS DISEASE AND OSTEOSARCOMA$193,003
R01 · FY2000 · AR